Compounds > azacitidine

azacitidine and Follicular Thyroid Carcinoma

azacitidine has been researched along with Follicular Thyroid Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Albulescu, A; Anton, G; Badiu, CV; Bostan, M; Botezatu, A; Dobrescu, R; Fudulu, A; Grancea, C; Huica, I; Iancu, IV; Manda, DA; Mihaila, M; Plesa, A; Vladoiu, SV1
Clark, OH; Duh, QY; Griff, NJ; Grogan, RH; Kebebew, E; Mitmaker, EJ; Sarkar, R; Shen, WT1
Dong, X; Korch, C; Meinkoth, JL1
Aldred, MA; Broelsch, CE; Eng, C; Frilling, A; Morrison, CD; Plass, C; Waite, KA; Weber, F1

Other Studies

4 other study(ies) available for azacitidine and Follicular Thyroid Carcinoma

ArticleYear
Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Cancer biomarkers : section A of Disease markers, 2020, Volume: 28, Issue:2

    Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Azacitidine; Biomarkers, Tumor; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Epigenesis, Genetic; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Young Adult

2020
Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors.
    Surgery, 2011, Volume: 149, Issue:4

    Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Papillary; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Thyroid Neoplasms; Valproic Acid

2011
Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.
    Endocrine-related cancer, 2011, Volume: 18, Issue:3

    Topics: Adenocarcinoma, Follicular; Azacitidine; Butyrates; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Decitabine; DNA Methylation; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasm Proteins; rap GTP-Binding Proteins; rap1 GTP-Binding Proteins; RNA, Small Interfering; Thyroid Neoplasms; Up-Regulation

2011
Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:2

    Topics: Adenocarcinoma, Follicular; Adenoma; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Decitabine; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Genomic Imprinting; Humans; Loss of Heterozygosity; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; Thyroid Neoplasms

2005